Manufacturers Have Withdrawn From Circulation [Validol And Naftizin]

Table of contents:

Manufacturers Have Withdrawn From Circulation [Validol And Naftizin]
Manufacturers Have Withdrawn From Circulation [Validol And Naftizin]

Video: Manufacturers Have Withdrawn From Circulation [Validol And Naftizin]

Video: Manufacturers Have Withdrawn From Circulation [Validol And Naftizin]
Video: Валидол и корвалол: реальная помощь или "пустышки" 2023, December
Anonim

Manufacturers have withdrawn from circulation [Validol and Naftizin]

Pharmaceutical companies have withdrawn a number of drugs from circulation in Russia, including some series of Validol tablets, Naftizin nasal drops, Hexoral Tabs and Asparkam tablets, the press service of the Federal Service for Surveillance in Healthcare reports. Medicines were recalled due to non-compliance with regulations.

Manufacturers have withdrawn from circulation [Validol and Naftizin]
Manufacturers have withdrawn from circulation [Validol and Naftizin]

Photo from the site klinfarm.org /

Pharmaceutical companies have withdrawn from circulation in Russia a number of drugs, including some series of Validol tablets, Naftizin nasal drops, Hexoral Tabs and Asparkam tablets, the press service of the Federal Service for Surveillance in Healthcare reports. Medicines were recalled due to non-compliance with regulations.

“The Federal Service for Surveillance in Healthcare informs that nine drugs have been withdrawn from circulation in the Russian Federation,” Roszdravnadzor reports.

DAV Pharm LLC withdrew nasal drops "Naftizin" (0.1%) in dropper bottles of 15 ml series 590813 due to the non-compliance of the drug with the requirements for the indicator "Microbiological purity".

OJSC Tatkhimfarmpreparaty withdraws from circulation the Validol sublingual tablets (60 mg), series 810313 produced by OJSC Tatkhimfarmpreparaty - the average weight of these tablets does not meet the regulatory requirements. In addition, Hexoral Tabs tablets, series 3010187 manufactured by Zoldan Holding + Bonbonspecialiteten GmbH (Germany), solution for injection "Nicotinic acid" series 350412, 431112, 441112 and Ortofen, series 280613, manufactured by JSC Moskhimfarmpreparaty were withdrawn from circulation them. Semashko”, tablets“Asparkam”series, 360513 produced by LLC“Pharmapol-Volga”; powder "Lingonberry leaves" series 010213 produced by LLC PKF "Fitofarm"; the drug "Cefazolin" series 200413 produced by LLC "Ruzfarma"; solution "Trometamol N" series 21003025 manufactured by Berlin-Chemi AG / Menarini Group (Germany).

Recommended: